Pentwater Capital Management LP - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 22 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Pentwater Capital Management LP ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$24,730,241
+6.1%
46,411,0000.0%0.13%
-17.4%
Q2 2023$23,308,486
+24.3%
46,411,0000.0%0.16%
-11.0%
Q1 2023$18,751,436
-25.9%
46,411,0000.0%0.18%
-59.2%
Q4 2022$25,320,496
-3.1%
46,411,0000.0%0.44%
+52.1%
Q3 2022$26,134,000
+3.5%
46,411,0000.0%0.29%
-1.7%
Q2 2022$25,262,000
+4.3%
46,411,0000.0%0.30%
+2.4%
Q1 2022$24,217,000
-2.2%
46,411,0000.0%0.29%
+7.8%
Q4 2021$24,770,00046,411,0000.27%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q3 2022
NameSharesValueWeighting ↓
PenderFund Capital Management Ltd. 17,454,000$9,8263.09%
Affinity Asset Advisors, LLC 7,500,000$3,008,2500.99%
DCF Advisers, LLC 3,600,000$1,476,0000.90%
Context Capital Management, LLC 21,851$8,7640.74%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 32,000,000$13,1200.48%
SILVERBACK ASSET MANAGEMENT LLC 6,250,000$2,500,0000.34%
WHITEBOX ADVISORS LLC 20,600,000$8,159,6600.28%
TENOR CAPITAL MANAGEMENT Co., L.P. 26,425,000$11,431,7480.23%
READYSTATE ASSET MANAGEMENT LP 5,500,000$2,206,0500.20%
DAVIDSON KEMPNER PARTNERS 25,000,000$9,432,5000.18%
View complete list of ESPERION THERAPEUTICS INC NE shareholders